This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Molecular Quality Controls Market

Third-party Quality Controls Drive the Adoption of Molecular Quality Controls System: FMI Conducts Market Research in 30+ Countries

Molecular Quality Controls Market by Analyte, Product Type, Application, End User & Region | Forecast 2023 to 2033

Molecular Quality Controls Market Outlook (2023 to 2033)

As per the recent market research conducted by FMI, the global molecular quality controls market is expected to be valued at US$ 204 million in 2023. The market is expected to advance at 7.2% CAGR during the forecast period. By 2033, the estimation is anticipated to surge past US$ 408 million.

Key factors that might propel the market growth are:

  • The surge in the clinical laboratories owing to rising diseases
  • Increasing consumer awareness regarding the importance of accreditation from government bodies
  • The rising dependence on third-party quality controls

Worldwide, there has been an exponential surge in people suffering from various diseases owing to a lot of factors. To meet the burgeoning demand for conducting laboratory tests for these patients, both public and private sector players are investing in molecular quality controls. These players develop processes that fall in line with the standards set by regulatory bodies, like International Organization for Standardization.

New multi-analyte and multi-instrument controls have been developed due to technological improvements. These cutting-edge controls combine many instrument-specific controls into a single control, allowing clinical laboratories to save money. These controls save time by eliminating the need for separate quality control processes for each analyte. Several companies have also added additional tests to their portfolios. For example, Bio-Rad Laboratories (USA) released the EDX RP Positive Run Control in February 2020. It was the first multi-analyte control that could target 22 analytes in a single vial, saving laboratories time and space on their instruments.

AcroMetrix Coronavirus 2019 (COVID-19) RNA Control was also launched by Thermo Fisher Scientific (USA) in April 2020 to monitor and validate COVID-19 molecular diagnostic assays. The increased availability of such molecular quality controls for infectious disease diagnostics and other applications is likely to drive market expansion.

Regulatory and legal requirements applied to including molecular diagnostics in the United States and European countries are becoming more stringent. As a result, new guidance documents are required to introduce any modifications to the device.

New applications may necessitate software upgrades, new software installation in an existing device, or other device modifications. Because of the low entry barriers, there is less dependence on the quality of molecular goods. There are no quality assurance requirements mandated for molecular diagnostic testing processes in India.

Currently, North America is the dominant market in terms of market share. The presence of key players in the region is believed to be one of the key factors for their market growth. The availability of technologically advanced options for molecular quality diagnostics is also driving market growth. However, in terms of growth rate, Asia Pacific is expected to be the leading market. The presence of developing nations that are investing massive amounts to upgrade healthcare infrastructure is expected to surge the market share.

Attributes

Value

Market Value (2022)

US$ 520.8 million

Market Expected Value (2023)

US$ 204 million

Market Forecast Value (2033)

US$ 408 million

Market Expected CAGR (2023 to 2033)

7.2%

Customize this Report

Let us know your requirement to get
100% FREE customization

Historical CAGR (2017 to 2021) Vs Anticipated CAGR

The medical field has been evolving consistently. With the inception of new kinds of viruses, the development seems to have taken an incremental speed. Taking the development aspect into consideration, healthcare experts have developed advanced techniques. For example, in January 2023, a group of experts from the University of Cambridge developed a new test for general respiratory viruses which makes use of DNA as a ‘bait’. Owing to this, it is anticipated that the adoption of molecular quality controls technique might reduce. The stats suggest that while the anticipated CAGR for the market is 7.2%, the historical CAGR for the market was 12.1%. Technological advancements and a higher focus on research and development can change the fortunes of the market in the longer run.

  • Short Term (2023 to 2026): At this point, more and more players would be working on technological developments. Companies like Qcnet are focusing on lot-to-lot reproducibility, which would help in maintaining the quality check. This method also assists in presenting a proper analysis of quantitative test results.
  • Mid Term (2026 to 2029): At this time frame, the manufacturers would be looking to integrate the process into software solutions. The labs might be getting access to quality check data management, which would provide access to inter-laboratory programs. The assessment tools and reports would help in understanding how far the compliance requirements have been met.
  • Long Term (2029 to 2033): With the roadmap set for product development, the market players would be willing to offer the best quality customer service. During this period, the market might witness an increase in skilled professionals. This would be amalgamated with technical support, software, and connectivity support.

What are the Restraints of the Molecular Quality Control Market?

Additional costs involved in quality control and budget constraints in hospitals and laboratories obstruct market growth. In a clinical laboratory, establishing a quality control process necessitates significant expenditure. Laboratories must also keep a dedicated staff to oversee the quality control system.

Quality control procedures entail equal expenses regardless of the number of tests completed. As a result, the cost of implementing quality control processes is prohibitively expensive for clinical laboratories doing modest quantities of diagnostic tests. These factors might challenge the adoption of quality control measures.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Molecular Quality Controls Market

Molecular Quality Controls Market:

Attributes

Molecular Quality Controls Market

Anticipated CAGR (2023 to 2033)

7.2%

Market Value (2023)

US$ 204 million

Growth Factor

Adoption of third-party quality control devices

Future Opportunities

Growing demand for multi-analyte controls

Market Trends

Technological upgradation in the molecular controls market

Point-of-care Molecular Diagnostics Market:

Attributes

Point-of-care Molecular Diagnostics Market

Anticipated CAGR (2023 to 2033)

8%

Market Value (2023)

US$ 4.32 billion

Growth Factor

Surging adoption of decentralized diagnostics

Future Opportunities

Conducive regulatory policies

Market Trends

The key players are focusing on developing economies

Cancer Diagnostics Market:

Attributes

Cancer Diagnostics Market

Anticipated CAGR (2023 to 2033)

7.1%

Market Value (2023)

US$ 195 billion

Growth Factor

Application of AI, which has increased the efficiency

Future Opportunities

Establishment of private diagnostic centers

Market Trends

Key players fixing issues related to reimbursement policies

Country-wise Insights

Regions North America
Countries United States
CAGR (2023 to 2033) 7%
Regions Europe
Countries United Kingdom
CAGR (2023 to 2033) 6.3%
Regions Asia Pacific
Countries China, Japan, India
CAGR (2023 to 2033) 6.6%, 5.7%, 5%

United States: Prevalence of Cystic Fibrosis to drive the Market Growth

The United States has been witnessing several cases of cystic fibrosis. Based on data published in Medlineplus, the disease occurs in 1 in 2,500 to 3,500 white newborns. The country has been going through massive upgradation in the healthcare infrastructure. Thus, there has been an improvement in the molecular quality controls devices too, as technological upgradation would improve the efficiency of molecular control devices.

Attributes

Details

United States Market Expected Size (2033)

US$ 144.5 million

United States Market Absolute Dollar Growth

US$ 70.8 million

CAGR % 2017 to 2022

11.7%

The region has been witnessing a surge in cancer cases as well. In 2022, more than 1.9 million cancer cases were reported in the United States. These numbers are expected to surge in the future. The oncologists make use of molecular quality control technique as it assists them in increasing the precision of the treatment.

United Kingdom: Increasing Geriatric Population to Assist Market Growth

The geriatric population has been surging exponentially in the United Kingdom. In 2021, nearly 11% of the population was above the age of 65 years. With improvement in the medical infrastructure, the figures might rise. The people of this age group are susceptible to all kinds of diseases. Thus, to maintain the efficacy of the treatment, doctors generally make use of molecular quality controls to identify the best treatment based on the patient's condition.

Attributes

Details

United Kingdom Market Expected Size (2033)

US$ 17.2 million

United Kingdom Market Absolute Dollar Growth

US$ 7.8 million

CAGR % 2017 to 2022

10.7%

Children suffering from Down’s Syndrome are quite high in the United Kingdom. As per the Down’s Syndrome Association, around 1 in 1,000 babies born in the country would be suffering from the disease. Doctors generally make use of molecular quality controls to understand the cause and treat the patients.

China: Increasing Cases of COVID-19 to Surge the Demand

China has been vulnerable to the COVID-19 pandemic right from the inception of the virus. Each week, at least 12,000 people are losing their lives. This has led to an increase in demand for molecular quality control devices as the clinical laboratories wanted to address the growing demand for testing solutions.

Attributes

Details

China Market Expected Size (2033)

US$ 29.3 million

China Market Absolute Dollar Growth

US$ 13.8 million

CAGR % 2017 to 2022

11.3%

People suffering from Lynch syndrome in China are believed to be one of the most severe kinds of diseases as it increases the probability of developing cancer. The doctors employ this infectious disease quality control technique as it allows them to take proactive measures when it comes to offering suitable treatment.

Japan: High cases of ovarian cancer to fuel the market growth

Women suffering from ovarian cancer are expected to propel the growth rate of the molecular quality control market. The numbers had risen from 4,758 in 2012 to more than 9,000 in 2018, as per AstraZeneca. Health experts make use of molecular quality controls to improve the efficacy of the existing procedures of treatment.

Attributes

Details

Japan Market Expected Size (2033)

US$ 23.9 million

Japan Market Absolute Dollar Growth

US$ 10.2 million

CAGR % 2017 to 2022

10.2%

Japan is virtually a hotspot for lifestyle diseases. Lack of proper nutrition has taken a toll on the health of many people. Consequently, they are suffering from several infectious diseases. The prevalence of sickle cell disease is also expected to surge the market share of molecular quality controls in the country.

India: Adoption of Third-party Quality Control to Drive Growth

The medical infrastructure has been evolving at a rapid pace in India. Owing to this, hospitals have started outsourcing certain important aspects of the business which they can afford to focus on other activities. A lot of hospitals are entering into a collaboration with third-party vendors for conducting operations based on molecular quality controls.

Attributes

Details

India Market Expected Size (2033)

US$ 14.1 million

India Market Absolute Dollar Growth

US$ 5.4 million

CAGR % 2017 to 2022

9.2%

Many children in India suffer from thalassemia. More than 10,000 children are born with this condition in India, and the survival rate is also not very high. These factors have led to the adoption of molecular quality control devices in hospitals.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Segmentation Insights

Segment Analyte
Attributes Single-analyte Controls
CAGR (2017 to 2022) 12%
CAGR (2023 to 2033) 7.1%
Segment End User
Attributes Diagnostic Laboratories
CAGR (2017 to 2022) 11.8%
CAGR (2023 to 2033) 6.4%

Which is the Most Preferred Form of Analyte?

Multiple hospitals and healthcare centers have started opting for single-analyte control as it is a more simplified way to assess and interpret better. These have a low risk of cross-reactivity, which makes them an upfront choice. However, with the development of healthcare, it is expected that the adoption of multi-analyte controls would surge in the future. The ability to cover dozens of parameters at a given time is expected to surge the adoption of multi-analyte controls.

Which End-user Segment is expected to Garner the leading Market Share?

Diagnostic laboratories account for the dominant share of the molecular quality control market. The growth can be attributed due to accredited diagnostic labs opening up. These labs provide their diagnostic services using molecular technology. Apart from that, diagnostic laboratories are entering into collaboration with hospitals, as a result of which they are garnering a huge market share. The diagnostics laboratories make use of QC techniques, which increases the reliability offered by them.

Start-ups Use High-throughput Single Cell Analyses for Research

The start-ups operating in the market make use of innovative molecular diagnostics techniques. They are implementing groundbreaking high-throughput single-cell analyses for clinical research, diagnostics, and drug development. The start-ups are also making use of innovative sustainable biomedical research that would aid in the advancement of medicine.

BostonGene: The start-up has been working on providing comprehensive molecular and immune profiling. This would certainly assist the healthcare workers in treatment. The solution provided by the start-up would aid in innovative clinical decision-making, and also promises to provide AI-backed research solutions for precision oncology. In April 2022, BostonGene raised US$ 150 million in the Series B round, propelling the company to unicorn status.

Manufacturers Offer a One-of-a-kind Mixed Reality Experience for Blood Donors

The key players operating in the market are introducing an innovative ‘mixed reality experience’ for use, which is specially designed for blood donors. The innovation is done to improve the experience and attract young blood donors to motivate them for donating blood. In January 2023, Abbott and Blood Centers of America launched first of its kind mixed reality experience for use during blood donation.

Key developments in the market:

  • In January 2023, Abbott received FDA approval for NAVIATOR, a next-generation TAVI system designed to treat aortic stenosis.
  • In September 2022, LGC’s new state-of-the-art site in Oxford delivered critical diagnostics solutions and research.

Dominant players in the market are

Company

Description

LGC

LGC is the leading global science tools company and has been providing mission-critical components and solutions to high-growth areas in the healthcare sector. LGC has been providing tools for genomics, which are typically embedded within the customers’ products. The company has been working for the progression of research and development, optimizing food production, and enhancing the quality of our food.

Abbott

Abbott has been creating breakthrough products in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. The company has been employing more than 113,000 people across the globe and has been working in more than 160 countries. The company has had the reputation of being Fortune’s most admired company for 9 years consecutively.

Microbiologics, Inc.

Microbiologics, Inc. is the world’s leading expert in biological products and services. For more than five decades, the company has been partnering with healthcare and life science laboratories across the globe to create and provide biological control materials, assay services, and consulting for microbiology, molecular diagnostics, and virology. As an award-winning company dedicated to improving operations and performance, the company is well-positioned for continuous success.

Other key players profiled: Thermo Fisher Scientific, Bio-Rad Laboratories, Inc.

Molecular Quality Controls Market Segmentation

By Analyte:

  • Single-analyte Controls
  • Multi-analyte Controls

By Product Type:

  • Independent controls
  • Instrument-specific controls

By Application:

  • Infectious Diseases Diagnostics
  • Oncology Testing and Genetic testing

By End User:

  • Diagnostic laboratories
  • Hospitals
  • IVD manufacturers & CROs
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East and Africa
  • Europe

Frequently Asked Questions

The molecular quality controls market is expected to hold US$ 204 million in 2023.

The molecular quality controls market is expected to advance at 7.2% CAGR from 2023 to 2033.

The molecular quality controls market is forecasted to surpass US$ 408 million by 2033.

North America is projected to be the dominant molecular quality control market.

The main drivers include the growing adoption of third-party quality controls, and surge in the clinical laboratories.

Table of Content

1. Executive Summary | Molecular Quality Controls Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Analyte

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Analyte, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Analyte, 2023 to 2033

        5.3.1. Single-analyte Controls

        5.3.2. Multi-analyte Controls

    5.4. Y-o-Y Growth Trend Analysis By Analyte, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Analyte, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        6.3.1. Independent Controls

        6.3.2. Instrument-specific Controls

    6.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033

        7.3.1. Infectious Diseases Diagnostics

        7.3.2. Oncology Testing and Genetic Testing

    7.4. Y-o-Y Growth Trend Analysis By Application , 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Diagnostic Laboratories

        8.3.2. Hospitals

        8.3.3. IVD Manufacturer & CROs

        8.3.4. Academic & Research Institutes

    8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. The USA

            10.2.1.2. Canada

        10.2.2. By Analyte

        10.2.3. By Product Type

        10.2.4. By Application

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Analyte

        10.3.3. By Product Type

        10.3.4. By Application

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Analyte

        11.2.3. By Product Type

        11.2.4. By Application

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Analyte

        11.3.3. By Product Type

        11.3.4. By Application

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. United Kingdom (UK)

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Analyte

        12.2.3. By Product Type

        12.2.4. By Application

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Analyte

        12.3.3. By Product Type

        12.3.4. By Application

        12.3.5. By End User

    12.4. Key Takeaways

13. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. India

            13.2.1.4. Thailand

            13.2.1.5. Singapore

            13.2.1.6. Australia

            13.2.1.7. Rest of Asia Pacific

        13.2.2. By Analyte

        13.2.3. By Product Type

        13.2.4. By Application

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Analyte

        13.3.3. By Product Type

        13.3.4. By Application

        13.3.5. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of Middle East and Africa

        14.2.2. By Analyte

        14.2.3. By Product Type

        14.2.4. By Application

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Analyte

        14.3.3. By Product Type

        14.3.4. By Application

        14.3.5. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Analyte

            15.1.2.2. By Product Type

            15.1.2.3. By Application

            15.1.2.4. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Analyte

            15.2.2.2. By Product Type

            15.2.2.3. By Application

            15.2.2.4. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Analyte

            15.3.2.2. By Product Type

            15.3.2.3. By Application

            15.3.2.4. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Analyte

            15.4.2.2. By Product Type

            15.4.2.3. By Application

            15.4.2.4. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Analyte

            15.5.2.2. By Product Type

            15.5.2.3. By Application

            15.5.2.4. By End User

    15.6. UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Analyte

            15.6.2.2. By Product Type

            15.6.2.3. By Application

            15.6.2.4. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Analyte

            15.7.2.2. By Product Type

            15.7.2.3. By Application

            15.7.2.4. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Analyte

            15.8.2.2. By Product Type

            15.8.2.3. By Application

            15.8.2.4. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Analyte

            15.9.2.2. By Product Type

            15.9.2.3. By Application

            15.9.2.4. By End User

    15.10. China

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Analyte

            15.10.2.2. By Product Type

            15.10.2.3. By Application

            15.10.2.4. By End User

    15.11. Japan

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Analyte

            15.11.2.2. By Product Type

            15.11.2.3. By Application

            15.11.2.4. By End User

    15.12. South Korea

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Analyte

            15.12.2.2. By Product Type

            15.12.2.3. By Application

            15.12.2.4. By End User

    15.13. Thailand

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Analyte

            15.13.2.2. By Product Type

            15.13.2.3. By Application

            15.13.2.4. By End User

    15.14. Singapore

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Analyte

            15.14.2.2. By Product Type

            15.14.2.3. By Application

            15.14.2.4. By End User

    15.15. Australia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Analyte

            15.15.2.2. By Product Type

            15.15.2.3. By Application

            15.15.2.4. By End User

    15.16. GCC Countries

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Analyte

            15.16.2.2. By Product Type

            15.16.2.3. By Application

            15.16.2.4. By End User

    15.17. South Africa

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Analyte

            15.17.2.2. By Product Type

            15.17.2.3. By Application

            15.17.2.4. By End User

    15.18. Israel

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Analyte

            15.18.2.2. By Product Type

            15.18.2.3. By Application

            15.18.2.4. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Analyte

        16.3.3. By Product Type

        16.3.4. By Application

        16.3.5. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Abbott

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. LGC Ltd

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Thermo Fisher Scientific

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Bio-Rad Laboratories, Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Microbiologics, Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Roche Diagnostics

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Zeptometrix LLC

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Quidel Corporation

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Maine Molecular Quality Controls, Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Bio-Techne Corporation

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Analyte, 2017 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 4: Global Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 5: Global Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Analyte, 2017 to 2033

Table 8: North America Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 9: North America Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 10: North America Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by Analyte, 2017 to 2033

Table 13: Latin America Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 14: Latin America Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 17: Europe Market Value (US$ Million) Forecast by Analyte, 2017 to 2033

Table 18: Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 19: Europe Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 20: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 22: Asia Pacific Market Value (US$ Million) Forecast by Analyte, 2017 to 2033

Table 23: Asia Pacific Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 24: Asia Pacific Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 25: Asia Pacific Market Value (US$ Million) Forecast by End User, 2017 to 2033

Table 26: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 27: Middle East and Africa Market Value (US$ Million) Forecast by Analyte, 2017 to 2033

Table 28: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Application , 2017 to 2033

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2017 to 2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Million) by Analyte, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Application , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by End User, 2023 to 2033

Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 6: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 9: Global Market Value (US$ Million) Analysis by Analyte, 2017 to 2033

Figure 10: Global Market Value Share (%) and BPS Analysis by Analyte, 2023 to 2033

Figure 11: Global Market Y-o-Y Growth (%) Projections by Analyte, 2023 to 2033

Figure 12: Global Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 13: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 14: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 15: Global Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 16: Global Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 17: Global Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 18: Global Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 21: Global Market Attractiveness by Analyte, 2023 to 2033

Figure 22: Global Market Attractiveness by Product Type, 2023 to 2033

Figure 23: Global Market Attractiveness by Application , 2023 to 2033

Figure 24: Global Market Attractiveness by End User, 2023 to 2033

Figure 25: Global Market Attractiveness by Region, 2023 to 2033

Figure 26: North America Market Value (US$ Million) by Analyte, 2023 to 2033

Figure 27: North America Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 28: North America Market Value (US$ Million) by Application , 2023 to 2033

Figure 29: North America Market Value (US$ Million) by End User, 2023 to 2033

Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by Analyte, 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by Analyte, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by Analyte, 2023 to 2033

Figure 37: North America Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 38: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 39: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 40: North America Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 41: North America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 42: North America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 43: North America Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 46: North America Market Attractiveness by Analyte, 2023 to 2033

Figure 47: North America Market Attractiveness by Product Type, 2023 to 2033

Figure 48: North America Market Attractiveness by Application , 2023 to 2033

Figure 49: North America Market Attractiveness by End User, 2023 to 2033

Figure 50: North America Market Attractiveness by Country, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) by Analyte, 2023 to 2033

Figure 52: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 53: Latin America Market Value (US$ Million) by Application , 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) by End User, 2023 to 2033

Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 59: Latin America Market Value (US$ Million) Analysis by Analyte, 2017 to 2033

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Analyte, 2023 to 2033

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Analyte, 2023 to 2033

Figure 62: Latin America Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 65: Latin America Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 71: Latin America Market Attractiveness by Analyte, 2023 to 2033

Figure 72: Latin America Market Attractiveness by Product Type, 2023 to 2033

Figure 73: Latin America Market Attractiveness by Application , 2023 to 2033

Figure 74: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 76: Europe Market Value (US$ Million) by Analyte, 2023 to 2033

Figure 77: Europe Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 78: Europe Market Value (US$ Million) by Application , 2023 to 2033

Figure 79: Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 84: Europe Market Value (US$ Million) Analysis by Analyte, 2017 to 2033

Figure 85: Europe Market Value Share (%) and BPS Analysis by Analyte, 2023 to 2033

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Analyte, 2023 to 2033

Figure 87: Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 88: Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 90: Europe Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 91: Europe Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 92: Europe Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 93: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 96: Europe Market Attractiveness by Analyte, 2023 to 2033

Figure 97: Europe Market Attractiveness by Product Type, 2023 to 2033

Figure 98: Europe Market Attractiveness by Application , 2023 to 2033

Figure 99: Europe Market Attractiveness by End User, 2023 to 2033

Figure 100: Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: Asia Pacific Market Value (US$ Million) by Analyte, 2023 to 2033

Figure 102: Asia Pacific Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 103: Asia Pacific Market Value (US$ Million) by Application , 2023 to 2033

Figure 104: Asia Pacific Market Value (US$ Million) by End User, 2023 to 2033

Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Analyte, 2017 to 2033

Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Analyte, 2023 to 2033

Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Analyte, 2023 to 2033

Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 118: Asia Pacific Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 121: Asia Pacific Market Attractiveness by Analyte, 2023 to 2033

Figure 122: Asia Pacific Market Attractiveness by Product Type, 2023 to 2033

Figure 123: Asia Pacific Market Attractiveness by Application , 2023 to 2033

Figure 124: Asia Pacific Market Attractiveness by End User, 2023 to 2033

Figure 125: Asia Pacific Market Attractiveness by Country, 2023 to 2033

Figure 126: Middle East and Africa Market Value (US$ Million) by Analyte, 2023 to 2033

Figure 127: Middle East and Africa Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 128: Middle East and Africa Market Value (US$ Million) by Application , 2023 to 2033

Figure 129: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033

Figure 130: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 131: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Analyte, 2017 to 2033

Figure 135: Middle East and Africa Market Value Share (%) and BPS Analysis by Analyte, 2023 to 2033

Figure 136: Middle East and Africa Market Y-o-Y Growth (%) Projections by Analyte, 2023 to 2033

Figure 137: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 138: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 139: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 140: Middle East and Africa Market Value (US$ Million) Analysis by Application , 2017 to 2033

Figure 141: Middle East and Africa Market Value Share (%) and BPS Analysis by Application , 2023 to 2033

Figure 142: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033

Figure 143: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2017 to 2033

Figure 144: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 145: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 146: Middle East and Africa Market Attractiveness by Analyte, 2023 to 2033

Figure 147: Middle East and Africa Market Attractiveness by Product Type, 2023 to 2033

Figure 148: Middle East and Africa Market Attractiveness by Application , 2023 to 2033

Figure 149: Middle East and Africa Market Attractiveness by End User, 2023 to 2033

Figure 150: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Viral Molecular Diagnostics Market

Published : January 1970

Google translate

Molecular Quality Controls Market